Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heart Rate Variability with Aripiprazole and Quetiapine in Schizophrenia and Bipolar Disorder
NCT01047215Phase 4Unknown
- Sponsor
- Taichung Veterans General Hospital
- Start
- Aug 2009
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of aripiprazole and quetiapine in schizophrenia and bipolar disorder (BD) (3 arms), sponsored by Taichung Veterans General Hospital. Primary endpoint: Heart Rate Variability. Status: unknown.
02
Drugs
aripiprazolequetiapine
03
Conditions
schizophreniabipolar disorder (BD)
Beyond the preview
Go deeper on NCT01047215.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01047215.